Korro Bio KRRO
NASDAQ KRRO
$12.94 +0.01 (+0.08%)
As of: Sep 10, 2026 · 2:59 PM EDT

Korro Bio (KRRO) Net Shares Issued and Repurchased (2018 - 2023)

Korro Bio's (KRRO) quarterly Net Shares Issued and Repurchased came in at $819050.0 in Q1 2023, up 225.44% on a YoY basis from $251677.0 in Q1 2022, and down 36.95% quarter-over-quarter from $1.3 million in Q4 2022.

Analysis

Korro Bio (KRRO) Net Shares Issued and Repurchased (2018 - 2023) Analysis & Trends

Korro Bio (KRRO) has reported Net Shares Issued and Repurchased for 6 consecutive years, with $819050.0 the latest figure, recorded in Q1 2023.

  • For the quarter ending Q1 2023, Net Shares Issued and Repurchased rose 225.44% year-over-year to $819050.0; the trailing twelve-month figure through Mar 2023 stood at $819050.0 (up 225.44% YoY), and the FY2022 full-year result was $1.3 million, down 4.3% from the prior year.
  • Net Shares Issued and Repurchased fell to $819050.0 in Q1 2023 per KRRO's latest filing, from $1.3 million in the prior quarter.
  • Across five years, Net Shares Issued and Repurchased topped out at $3.0 million in Q4 2019 and bottomed at $251677.0 in Q1 2022.
  • Historically, Net Shares Issued and Repurchased has averaged $1.3 million across 5 years, with a median of $1.2 million in 2021.
  • The sharpest annual moves came in 2022 and 2023: Net Shares Issued and Repurchased slumped 77.9% in 2022, then surged 225.44% in 2023.
  • Over 5 years, Net Shares Issued and Repurchased stood at $3.0 million in 2019, then slumped by 45.42% to $1.6 million in 2020, then fell by 17.52% to $1.4 million in 2021, then fell by 4.3% to $1.3 million in 2022, then plunged by 36.95% to $819050.0 in 2023.
  • According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $819050.0, $1.3 million, and $251677.0 for Q1 2023, Q4 2022, and Q1 2022 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Amgen 206.78 Bn 192.79 Bn 7.24 Bn -
2 Gilead Sciences 179.92 Bn 176.74 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 131.39 Bn 123.54 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.91 Bn 73.91 Bn 3.93 Bn -
5 Argenx Se 60.35 Bn 55.17 Bn 1.37 Bn -
6 Moderna 53.67 Bn 48.54 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.12 Bn 29.81 Bn 992.69 Mn -
8 Biogen 31.92 Bn 30.63 Bn 1.96 Bn -
9 Roivant Sciences 29.23 Bn 29.23 Bn 1.16 Mn -
10 Korro Bio 227.98 Mn 112.95 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 819,050.00
Dec 31, 2022 1.30 Mn
Mar 31, 2022 251,677.00
Dec 31, 2021 1.36 Mn
Mar 31, 2021 1.14 Mn
Dec 31, 2020 1.65 Mn
Mar 31, 2020 1.11 Mn
Dec 31, 2019 3.02 Mn
Dec 31, 2018 1.44 Mn